News + Filings Charts Transactions Holdings
All
13F
13D/G
Other
|
|
BML Investment Partners, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/24/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/17/2023 |
SC 13G
| BML Investment Partners, L.P. reports a 5.1% stake in Quince Therapeutics, Inc. |
| 04/27/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/27/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/17/2023 |
SC 13G
| BML Investment Partners, L.P. reports a 5.2% stake in Embark Technology, Inc. |
| 02/02/2023 |
SC 13G
| BML Investment Partners, L.P. reports a 5.6% stake in Surrozen, Inc./DE |
| 01/26/2023 |
SC 13G
| BML Investment Partners, L.P. reports a 7.7% stake in Cyteir Therapeutics, Inc. |
| 01/09/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/30/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/01/2022 |
SC 13G
| BML Investment Partners, L.P. reports a 5.7% stake in Graybug Vision, INC. |
| 11/16/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/07/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/10/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/04/2022 |
SC 13G
| BML Investment Partners, L.P. reports a 6.5% stake in Eliem Therapeutics, Inc. |
| 05/04/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/14/2022 |
SC 13G
| BML Investment Partners, L.P. reports a 6.2% stake in IMARA INC |
| 03/10/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/10/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/17/2022 |
SC 13G
| BML Investment Partners, L.P. reports a 5.9% stake in Metacrine, Inc. |
| 01/28/2022 |
SC 13G
| BML Investment Partners, L.P. reports a 7.4% stake in Odonate Therapeutics Inc |
| 01/27/2022 |
SC 13G
| BML Investment Partners, L.P. reports a 5.3% stake in ARCA Biopharma, INC. |
| 07/22/2021 |
SC 13G
| BML Investment Partners, L.P. reports a 5.1% stake in LUBYS INC |
| 10/27/2020 |
SC 13G
| BML Investment Partners, L.P. reports a 5.3% stake in ACELRX PHARMACEUTICALS, INC. |
| 10/27/2020 |
SC 13G
| BML Investment Partners, L.P. reports a 5.3% stake in ACELRX PHARMACEUTICALS, INC. |
| 08/21/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/09/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/22/2019 |
SC 13G
| BML Investment Partners, L.P. reports a 6.3% stake in Support.com, Inc. |
| 07/29/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/17/2019 |
SC 13G
| BML Investment Partners, L.P. reports a 9.7% stake in Vaxart, Inc. |
| 11/06/2018 |
SC 13G
| BML Investment Partners, L.P. reports a 5.2% stake in Communications Systems, Inc |
| 10/04/2018 |
SC 13G
| BML Investment Partners, L.P. reports a 5.1% stake in Opthotech Corporation |
| 08/20/2018 |
SC 13G
| BML Investment Partners, L.P. reports a 7.4% stake in Orchids Paper Products |
|
|
|